期刊文献+

三阴性确切谱系垂体神经内分泌肿瘤12例临床病理分析

Pituitary neuroendocrine tumors with triple-negative definite lineage:a clinicopathological analysis of 12 cases
下载PDF
导出
摘要 目的探讨三阴性确切谱系垂体神经内分泌肿瘤(PitNETs)的病理学特点及临床意义。方法收集中国科学技术大学附属第一医院2019至2023年诊断的垂体三阴性确切谱系PitNETs12例,整理临床及病理学资料。结果12例中男性6例,女性6例,平均年龄52.2岁。3例为复发性PitNETs,4例表现为头痛、视力下降,5例因体检发现。磁共振增强显示不均匀强化,直径1.5~4.2 cm。7例为SF1谱系,4例为TPIT谱系、1例为PIT1谱系。免疫组化显示12例SF1、TPIT和PIT1均阴性;7例SF1谱系中GATA-3均阳性,3例ER部分阳性,7例LH、FSH均阳性;4例TPIT谱系中1例GATA-3阳性,ER均阴性,ACTH均阳性;1例PIT1谱系中GATA-3阴性,ER阴性,PRL阳性。结论垂体三阴性确切谱系PitNETs是一类罕见的PitNETs,临床表现为具有侵袭性的大腺瘤或巨大腺瘤,易复发,预后相对较差,需要密切随访。病理学特点主要表现为转录因子SF1、TPIT和PIT1均阴性,但该谱系的激素阳性,以SF1谱系激素LH、FSH为主,易被误诊为零细胞肿瘤,需进行鉴别诊断。正确识别该类型肿瘤,对于PitNETs的精准分类及临床诊疗有重要的意义。 Objective To explore pathological features and the clinical significance of triple-negative pituitary neuroendocrine tumors(PitNETs)with specific lineages.Methods We collected data from 12 cases of triple-negative PitNETs diagnosed at the First Affiliated Hospital of the USTC from October 2019 to October 2023.Clinical and pathological information was compiled for analysis.Results Among the 12 cases,there were 6 males and 6 females,with an average age of 52.2 years.Three cases were recurrent PitNETs,4 cases presented with headaches and visual impairment,and 5 cases were discovered during routine medical examinations.Magnetic resonance imaging revealed irregularly enhanced lesions with diameters ranging from 1.5 to 4.2 cm.Pathological diagnoses included 7 cases of SF1 lineage,4 cases of TPIT lineage,and 1 case of PIT1 lineage PitNETs.Immunohistochemistry showed negative expression for SF1,TPIT,and PIT1 in all 12 cases.Among the SF1 lineage cases,7 were positive for GATA-3,3 were partially positive for ER,and all 7 were positive for LH and FSH.In the TPIT lineage cases,1 was positive for GATA-3,all were negative for ER,and all were positive for ACTH.In the PIT1 lineage case,GATA-3 was negative,ER was negative,and PRL was positive.Conclusions Triple-negative Pit-NETs with specific lineages are a rare subtype,The clinical manifestations are invasive macroadenomas or giant adenomas,which are prone to recurrence and have a relatively poor prognosis,requiring close follow-up.These tumors are characterized by the absence of transcription factors SF1,TPIT,and PIT1,while exhibiting hormone positivity.The SF1 lineage hormones LH and FSH are mainly misdiagnosed as zero-cell tumors,and differential diagnosis is needed.The correct identification of this type of tumor is of great significance for the accurate classification and clinical diagnosis and treatment of PitNETs.
作者 王武 程岚卿 王月娥 葛冲 黄亮亮 李玉洁 吴海波 张安莉 WANG Wu;CHENG Lan-qing;WANG Yue-e;GE Chong;HUANG Liang-liang;LI Yu-jie;WU Hai-bo;ZHANG An-li(Department of Pathology,the First Affiliated Hospital of University of Science and Technology of China/Anhui Provincial Hospital,Hefei 230036,China)
出处 《诊断病理学杂志》 2024年第8期723-727,共5页 Chinese Journal of Diagnostic Pathology
关键词 垂体神经内分泌肿瘤 SF1谱系 TPIT谱系 PIT1谱系 Pituitary neuroendocrine tumor SF1-lineage TPIT-lineage PIT1-lineage
  • 相关文献

参考文献3

二级参考文献21

  • 1Ordóez NG.Value of GATA3 immunostaining in tumor diagnosis:a review[J].Adv Anat Pathol,2013,20(5):352-360.
  • 2Bhargava R,Beriwal S,Dabbs DJ.Mammaglobin vs GCDFP-15:an immunohistologic validation survey for sensitivity and specificity[J].Am J Clin Pathol,2007,127(1):103-113.
  • 3Chia SY,Thike AA,Cheok PY,et al.Utility of mammaglobin and gross cystic disease fluid protein-15(GCDFP-15)in confirming a breast origin for recurrent tumors[J].Breast,2010,19(5):355-359.
  • 4Rollins-Raval M,Chivukula M,Tseng GC,et al.An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature[J].Arch Pathol Lab Med,2011,135(8):975-983.
  • 5Gulbahce HE,Sweeney C,Surowiecka M,et al.Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and/or hormonal therapy and clinicopathologic features of GATA-3 positive tumors[J].Hum Pathol,2013,44(11):2427-2431.
  • 6Miettinen M,Mc Cue PA,Sariomo-Rikala M,et al.GATA3:a multispecific but potentially useful marker in surgical pathology:a systematic analysis of 2500 epithelial and nonepithelial tumors[J].Am J Surg Pathol,2014,38(1):13-22.
  • 7Cimino-Mathews A,Subhawong AP,Illei PB,et al.GATA3expression in breast carcinoma:utility in triple-negative,sarcomatoid,and metastatic carcinomas[J].Hum Pathol,2013,44(7):1341-1349.
  • 8Shield PW,Papadimos DJ,Walsh MD.GATA3:a promising marker for metastatic breast carcinoma in serous effusion specimens[J].Cancer Cytopathol,2014,122(4):307-312.
  • 9Ghaffari SR,Sabokbar T,Tahmasebi S,et al.Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers:a molecular study of 59 patients[J].Asian Pac J Cancer Prev,2006,7(3):396-398.
  • 10Mazoujian G,Warhol MJ,Haagensen DE.The ultrastructural localization of gross cystic disease fluid protein(GCDFP-15)in breast epithelium[J].Am J Pathol,1984,116(2):305-310.

共引文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部